Y Gelfand - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Y Gelfand

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Bone Marrow Transplantation|January 10, 2002

Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytesS Slavin, A Ackerstein, S Morecki, et al.

Cancer Immunology, Immunotherapy : CII|February 9, 2000

Induction of antitumor immunity by indomethacinS Morecki, E Yacovlev, Y Gelfand, et al.

American Journal of Ophthalmology|February 1, 2000

Multiple retinal arteriolar occlusions associated with coexisting primary antiphospholipid syndrome and factor V Leiden mutationD Dori, I Beiran, Y Gelfand, et al.

Bone Marrow Transplantation|October 25, 2011

Selective elimination of alloreactivity in vitro and in vivo while sparing other T-cell-mediated immune responsesS Morecki, Y Gelfand, E Yacovlev, et al.

Journal of Hematotherapy|April 1, 1997

Activated long-term peripheral blood cultures as preparation for adoptive alloreactive cell therapy in cancer patientsS Morecki, Y Gelfand, S Levi, et al.

Bone Marrow Transplantation|September 6, 2001

Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimenS Morecki, Y Gelfand, A Nagler, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Bone Marrow Transplantation|January 10, 2002

Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytesS Slavin, A Ackerstein, S Morecki, et al.

Cancer Immunology, Immunotherapy : CII|February 9, 2000

Induction of antitumor immunity by indomethacinS Morecki, E Yacovlev, Y Gelfand, et al.

American Journal of Ophthalmology|February 1, 2000

Multiple retinal arteriolar occlusions associated with coexisting primary antiphospholipid syndrome and factor V Leiden mutationD Dori, I Beiran, Y Gelfand, et al.

Bone Marrow Transplantation|October 25, 2011

Selective elimination of alloreactivity in vitro and in vivo while sparing other T-cell-mediated immune responsesS Morecki, Y Gelfand, E Yacovlev, et al.

Journal of Hematotherapy|April 1, 1997

Activated long-term peripheral blood cultures as preparation for adoptive alloreactive cell therapy in cancer patientsS Morecki, Y Gelfand, S Levi, et al.

Bone Marrow Transplantation|September 6, 2001

Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimenS Morecki, Y Gelfand, A Nagler, et al.

Pageof 2